# AEVEX Corp.: financial statements, quarterly

AVEX · NYSE · CIK 2096300 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/avex.md) · [Financials](/companies/avex/financials.md) · [Filings](/companies/avex/filings.md) · [Insiders](/companies/avex/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/avex/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [101](/filings/0002096300-26-000022.md) | not reported | [202](/filings/0002096300-26-000022.md) |
| Cost of revenue | $m | not reported | [82.8](/filings/0002096300-26-000022.md) | not reported | [154](/filings/0002096300-26-000022.md) |
| Gross profit | $m | not reported | [18.4](/filings/0002096300-26-000022.md) | not reported | [47.6](/filings/0002096300-26-000022.md) |
| Research and development | $m | not reported | [7.2](/filings/0002096300-26-000022.md) | not reported | [5.6](/filings/0002096300-26-000022.md) |
| Selling, general and administrative | $m | not reported | [9.4](/filings/0002096300-26-000022.md) | not reported | [22.5](/filings/0002096300-26-000022.md) |
| Operating income | $m | not reported | [(3.5)](/filings/0002096300-26-000022.md) | not reported | [15.4](/filings/0002096300-26-000022.md) |
| Interest expense | $m | not reported | [8.4](/filings/0002096300-26-000022.md) | not reported | [4.0](/filings/0002096300-26-000022.md) |
| Income tax | $m | not reported | [0.0](/filings/0002096300-26-000022.md) | not reported | [2.5](/filings/0002096300-26-000022.md) |
| Net income | $m | [(27.3)](/filings/0002096300-26-000022.md) | [(11.8)](/filings/0002096300-26-000022.md) | [21.0](/filings/0002096300-26-000022.md) | [2.3](/filings/0002096300-26-000022.md) |
| Diluted EPS | $ per share | not reported | [0.00](/filings/0002096300-26-000022.md) | not reported | [0.01](/filings/0002096300-26-000022.md) |
| Basic EPS | $ per share | not reported | [0.00](/filings/0002096300-26-000022.md) | not reported | [0.01](/filings/0002096300-26-000022.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-12-31) | period not labelled (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [27.9](/filings/0002096300-26-000022.md) | [0.0](/filings/0002096300-26-000012.md) | [215](/filings/0002096300-26-000022.md) |
| Current assets | $m | not reported | not reported | not reported | [190](/filings/0002096300-26-000022.md) | not reported | [431](/filings/0002096300-26-000022.md) |
| Total assets | $m | not reported | not reported | not reported | [627](/filings/0002096300-26-000022.md) | [0.0](/filings/0002096300-26-000012.md) | [948](/filings/0002096300-26-000022.md) |
| Current liabilities | $m | not reported | not reported | not reported | [62.5](/filings/0002096300-26-000022.md) | not reported | [76.2](/filings/0002096300-26-000022.md) |
| Total liabilities | $m | not reported | not reported | not reported | [343](/filings/0002096300-26-000022.md) | [0.0](/filings/0002096300-26-000012.md) | [275](/filings/0002096300-26-000022.md) |
| Long-term debt | $m | not reported | not reported | not reported | [256](/filings/0002096300-26-000022.md) | not reported | [96.6](/filings/0002096300-26-000022.md) |
| Current portion of debt | $m | not reported | not reported | not reported | [2.7](/filings/0002096300-26-000022.md) | not reported | [2.5](/filings/0002096300-26-000022.md) |
| Shareholders' equity | $m | [164](/filings/0002096300-26-000022.md) | [137](/filings/0002096300-26-000022.md) | [187](/filings/0002096300-26-000022.md) | [199](/filings/0002096300-26-000022.md) | [0.0](/filings/0002096300-26-000012.md) | [(534)](/filings/0002096300-26-000022.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Shares

| Line item | Unit | period not labelled (2025-06-30) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.0](/filings/0002096300-26-000022.md) | [52.8](/filings/0002096300-26-000022.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.